Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor

A randomized controlled trial

Deirdre J. Lyell, Kristin Pullen, Laura Campbell, Suzanne Ching, Maurice L. Druzin, Usha Chitkara, Demetra Burrs, Aaron Caughey, Yasser Y. El-Sayed

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

OBJECTIVE: To compare the efficacy and side effects of intravenous magnesium to oral nifedipine for acute tocolysis of preterm labor. METHODS: A multicenter randomized trial was performed. Patients in active preterm labor who were at 24 to 33 weeks and 6 days of gestation were randomly assigned to receive magnesium sulfate or nifedipine. The primary outcome was arrest of preterm labor, defined as prevention of delivery for 48 hours with uterine quiescence. RESULTS: One hundred ninety-two patients were enrolled. More patients assigned to magnesium sulfate achieved the primary outcome (87% compared with 72%, P=.01). There were no differences in delivery within 48 hours (7.6% magnesium sulfate compared with 8.0% nifedipine, P=.92), gestational age at delivery (35.8 compared with 36.0 weeks, P=.61), birth before 37 and 32 weeks (57% compared with 57%, P=.97, and 11% compared with 8%, P=.39), and episodes of recurrent preterm labor. Mild and severe maternal adverse effects were significantly more frequent with magnesium sulfate. Birth weight, birth weight less than 2,500 g, and neonatal morbidities were similar between groups, but newborns in the magnesium sulfate group spent longer in the neonatal intensive care unit (8.8±17.7 compared with 4.2±8.2 days, P=.007). CONCLUSION: Patients who received magnesium sulfate achieved the primary outcome more frequently. However, delay of delivery, gestational age at delivery, and neonatal outcomes were similar between groups. Nifedipine was associated with fewer maternal adverse effects. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00185900

Original languageEnglish (US)
Pages (from-to)61-67
Number of pages7
JournalObstetrics and Gynecology
Volume110
Issue number1
DOIs
StatePublished - Jul 2007
Externally publishedYes

Fingerprint

Tocolysis
Magnesium Sulfate
Premature Obstetric Labor
Nifedipine
Randomized Controlled Trials
Birth Weight
Gestational Age
Neonatal Intensive Care Units
Magnesium
Multicenter Studies
Clinical Trials
Parturition
Newborn Infant
Morbidity
Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Lyell, D. J., Pullen, K., Campbell, L., Ching, S., Druzin, M. L., Chitkara, U., ... El-Sayed, Y. Y. (2007). Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: A randomized controlled trial. Obstetrics and Gynecology, 110(1), 61-67. https://doi.org/10.1097/01.AOG.0000269048.06634.35

Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor : A randomized controlled trial. / Lyell, Deirdre J.; Pullen, Kristin; Campbell, Laura; Ching, Suzanne; Druzin, Maurice L.; Chitkara, Usha; Burrs, Demetra; Caughey, Aaron; El-Sayed, Yasser Y.

In: Obstetrics and Gynecology, Vol. 110, No. 1, 07.2007, p. 61-67.

Research output: Contribution to journalArticle

Lyell, DJ, Pullen, K, Campbell, L, Ching, S, Druzin, ML, Chitkara, U, Burrs, D, Caughey, A & El-Sayed, YY 2007, 'Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: A randomized controlled trial', Obstetrics and Gynecology, vol. 110, no. 1, pp. 61-67. https://doi.org/10.1097/01.AOG.0000269048.06634.35
Lyell, Deirdre J. ; Pullen, Kristin ; Campbell, Laura ; Ching, Suzanne ; Druzin, Maurice L. ; Chitkara, Usha ; Burrs, Demetra ; Caughey, Aaron ; El-Sayed, Yasser Y. / Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor : A randomized controlled trial. In: Obstetrics and Gynecology. 2007 ; Vol. 110, No. 1. pp. 61-67.
@article{d1373447d27f49ec94966774fb3a460c,
title = "Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: A randomized controlled trial",
abstract = "OBJECTIVE: To compare the efficacy and side effects of intravenous magnesium to oral nifedipine for acute tocolysis of preterm labor. METHODS: A multicenter randomized trial was performed. Patients in active preterm labor who were at 24 to 33 weeks and 6 days of gestation were randomly assigned to receive magnesium sulfate or nifedipine. The primary outcome was arrest of preterm labor, defined as prevention of delivery for 48 hours with uterine quiescence. RESULTS: One hundred ninety-two patients were enrolled. More patients assigned to magnesium sulfate achieved the primary outcome (87{\%} compared with 72{\%}, P=.01). There were no differences in delivery within 48 hours (7.6{\%} magnesium sulfate compared with 8.0{\%} nifedipine, P=.92), gestational age at delivery (35.8 compared with 36.0 weeks, P=.61), birth before 37 and 32 weeks (57{\%} compared with 57{\%}, P=.97, and 11{\%} compared with 8{\%}, P=.39), and episodes of recurrent preterm labor. Mild and severe maternal adverse effects were significantly more frequent with magnesium sulfate. Birth weight, birth weight less than 2,500 g, and neonatal morbidities were similar between groups, but newborns in the magnesium sulfate group spent longer in the neonatal intensive care unit (8.8±17.7 compared with 4.2±8.2 days, P=.007). CONCLUSION: Patients who received magnesium sulfate achieved the primary outcome more frequently. However, delay of delivery, gestational age at delivery, and neonatal outcomes were similar between groups. Nifedipine was associated with fewer maternal adverse effects. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00185900",
author = "Lyell, {Deirdre J.} and Kristin Pullen and Laura Campbell and Suzanne Ching and Druzin, {Maurice L.} and Usha Chitkara and Demetra Burrs and Aaron Caughey and El-Sayed, {Yasser Y.}",
year = "2007",
month = "7",
doi = "10.1097/01.AOG.0000269048.06634.35",
language = "English (US)",
volume = "110",
pages = "61--67",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor

T2 - A randomized controlled trial

AU - Lyell, Deirdre J.

AU - Pullen, Kristin

AU - Campbell, Laura

AU - Ching, Suzanne

AU - Druzin, Maurice L.

AU - Chitkara, Usha

AU - Burrs, Demetra

AU - Caughey, Aaron

AU - El-Sayed, Yasser Y.

PY - 2007/7

Y1 - 2007/7

N2 - OBJECTIVE: To compare the efficacy and side effects of intravenous magnesium to oral nifedipine for acute tocolysis of preterm labor. METHODS: A multicenter randomized trial was performed. Patients in active preterm labor who were at 24 to 33 weeks and 6 days of gestation were randomly assigned to receive magnesium sulfate or nifedipine. The primary outcome was arrest of preterm labor, defined as prevention of delivery for 48 hours with uterine quiescence. RESULTS: One hundred ninety-two patients were enrolled. More patients assigned to magnesium sulfate achieved the primary outcome (87% compared with 72%, P=.01). There were no differences in delivery within 48 hours (7.6% magnesium sulfate compared with 8.0% nifedipine, P=.92), gestational age at delivery (35.8 compared with 36.0 weeks, P=.61), birth before 37 and 32 weeks (57% compared with 57%, P=.97, and 11% compared with 8%, P=.39), and episodes of recurrent preterm labor. Mild and severe maternal adverse effects were significantly more frequent with magnesium sulfate. Birth weight, birth weight less than 2,500 g, and neonatal morbidities were similar between groups, but newborns in the magnesium sulfate group spent longer in the neonatal intensive care unit (8.8±17.7 compared with 4.2±8.2 days, P=.007). CONCLUSION: Patients who received magnesium sulfate achieved the primary outcome more frequently. However, delay of delivery, gestational age at delivery, and neonatal outcomes were similar between groups. Nifedipine was associated with fewer maternal adverse effects. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00185900

AB - OBJECTIVE: To compare the efficacy and side effects of intravenous magnesium to oral nifedipine for acute tocolysis of preterm labor. METHODS: A multicenter randomized trial was performed. Patients in active preterm labor who were at 24 to 33 weeks and 6 days of gestation were randomly assigned to receive magnesium sulfate or nifedipine. The primary outcome was arrest of preterm labor, defined as prevention of delivery for 48 hours with uterine quiescence. RESULTS: One hundred ninety-two patients were enrolled. More patients assigned to magnesium sulfate achieved the primary outcome (87% compared with 72%, P=.01). There were no differences in delivery within 48 hours (7.6% magnesium sulfate compared with 8.0% nifedipine, P=.92), gestational age at delivery (35.8 compared with 36.0 weeks, P=.61), birth before 37 and 32 weeks (57% compared with 57%, P=.97, and 11% compared with 8%, P=.39), and episodes of recurrent preterm labor. Mild and severe maternal adverse effects were significantly more frequent with magnesium sulfate. Birth weight, birth weight less than 2,500 g, and neonatal morbidities were similar between groups, but newborns in the magnesium sulfate group spent longer in the neonatal intensive care unit (8.8±17.7 compared with 4.2±8.2 days, P=.007). CONCLUSION: Patients who received magnesium sulfate achieved the primary outcome more frequently. However, delay of delivery, gestational age at delivery, and neonatal outcomes were similar between groups. Nifedipine was associated with fewer maternal adverse effects. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00185900

UR - http://www.scopus.com/inward/record.url?scp=34347366436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347366436&partnerID=8YFLogxK

U2 - 10.1097/01.AOG.0000269048.06634.35

DO - 10.1097/01.AOG.0000269048.06634.35

M3 - Article

VL - 110

SP - 61

EP - 67

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 1

ER -